Benthic Genomics
Private Company
Total funding raised: $3.8M
Overview
Benthic Genomics is a private, early-stage bioinformatics company founded in 2021 and based in Cambridge, Massachusetts. It has developed a proprietary software analysis platform that leverages an advanced, graph-based reference to deliver superior genotyping accuracy and resolution in complex immune genomic regions from multiple data types, including microarrays and NGS. The company appears to be pre-revenue, operating a platform business model focused on providing analytical tools to research and clinical labs. Its primary value proposition is enabling high-performance, cost-effective analysis of critical genomic regions that are traditionally difficult to characterize.
Technology Platform
Proprietary pan-immune reference graph and associated algorithms for high-resolution genotyping, phasing, and variant calling in complex genomic regions (HLA, KIR, pharmacogenes) from microarray, short-read, and long-read sequencing data.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with academic HLA/KIR typing tools (e.g., from NIH-funded projects) and broader bioinformatics suites from companies like Illumina, Qiagen, and DNAnexus. Its differentiation lies in its specialized, graph-based reference and focus on extracting maximum resolution from cost-effective data types like microarrays.